{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:50:34Z","timestamp":1774435834866,"version":"3.50.1"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["(01KI07145) 2001-2011"],"award-info":[{"award-number":["(01KI07145) 2001-2011"]}]},{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Despite improvements in medical science and public health, mortality of community-acquired pneumonia (CAP) has barely changed throughout the last 15\u00a0years. The current SARS-CoV-2 pandemic has once again highlighted the central importance of acute respiratory infections to human health. The \u201cnetwork of excellence on Community Acquired Pneumonia\u201d (CAPNETZ) hosts the most comprehensive CAP database worldwide including more than 12,000 patients. CAPNETZ connects physicians, microbiologists, virologists, epidemiologists, and computer scientists throughout Europe. Our aim was to summarize the current situation in CAP research and identify the most pressing unmet needs in CAP research.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To identify areas of future CAP research, CAPNETZ followed a multiple-step procedure. First, research members of CAPNETZ were individually asked to identify unmet needs. Second, the top 100 experts in the field of CAP research were asked for their insights about the unmet needs in CAP (Delphi approach). Third, internal and external experts discussed unmet needs in CAP at a scientific retreat.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eleven topics for future CAP research were identified: detection of causative pathogens, next generation sequencing for antimicrobial treatment guidance, imaging diagnostics, biomarkers, risk stratification, antiviral and antibiotic treatment, adjunctive therapy, vaccines and prevention, systemic and local immune response, comorbidities, and long-term cardio-vascular complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pneumonia is a complex disease where the interplay between pathogens, immune system and comorbidities not only impose an immediate risk of mortality but also affect the patients\u2019 risk of developing comorbidities as well as mortality for up to a decade after pneumonia has resolved. Our review of unmet needs in CAP research has shown that there are still major shortcomings in our knowledge of CAP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02117-3","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T08:20:46Z","timestamp":1662798046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group"],"prefix":"10.1186","volume":"23","author":[{"given":"Mathias W.","family":"Pletz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas Vestergaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Bahrs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grit","family":"Barten-Neiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kolditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang M.","family":"Kuebler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gernot","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,10]]},"reference":[{"key":"2117_CR1","unstructured":"Osler W, McCrae T. The principles and practice of medicine. New York, London: D. Appleton and company; 1920. http:\/\/archive.org\/details\/principlesandpr00mccrgoog. Accessed 15 May 2019."},{"key":"2117_CR2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(17)31833-0","volume":"390","author":"H Wang","year":"2017","unstructured":"Wang H, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1084\u2013150.","journal-title":"Lancet"},{"key":"2117_CR3","doi-asserted-by":"crossref","unstructured":"Chalmers JD, Pletz MW, Aliberti S. European respiratory monograph community-acquired pneumonia. European Respiratory Society; 2014.","DOI":"10.1183\/1025448x.erm6314"},{"key":"2117_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","volume":"398","author":"S Aliberti","year":"2021","unstructured":"Aliberti S, Cruz CSD, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet. 2021;398:906\u201319.","journal-title":"Lancet"},{"key":"2117_CR5","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR6","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","volume":"64","author":"WS Lim","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Jeune IL, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64:iii1\u201355.","journal-title":"Thorax"},{"key":"2117_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0042-101873","volume":"70","author":"S Ewig","year":"2016","unstructured":"Ewig S, H\u00f6ffken G, Kern W, Rohde G, Flick H, Krause R, et al. Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Pr\u00e4vention\u2014Update 2016. Pneumologie. 2016;70:151\u2013200.","journal-title":"Pneumologie"},{"key":"2117_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12890-017-0404-8","volume":"17","author":"GB Egelund","year":"2017","unstructured":"Egelund GB, Jensen AV, Andersen SB, Petersen PT, Lindhardt B\u00d8, von Plessen C, et al. Penicillin treatment for patients with community-acquired pneumonia in Denmark: a retrospective cohort study. BMC Pulm Med. 2017;17:66.","journal-title":"BMC Pulm Med"},{"key":"2117_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","volume":"68","author":"A Torres","year":"2013","unstructured":"Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68:1057\u201365.","journal-title":"Thorax"},{"key":"2117_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/thx.2008.109785","volume":"64","author":"S Ewig","year":"2009","unstructured":"Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009;64:1062\u20139.","journal-title":"Thorax"},{"issue":"8","key":"2117_CR11","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.rmed.2014.05.004","volume":"108","author":"M S\u00f8gaard","year":"2014","unstructured":"S\u00f8gaard M, Nielsen RB, Sch\u00f8nheyder HC, N\u00f8rgaard M, Thomsen RW. Nationwide trends in pneumonia hospitalization rates and mortality, Denmark 1997\u20132011. Respir Med. 2014;108(8):1214\u201322.","journal-title":"Respir Med"},{"issue":"6","key":"2117_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10096-018-3224-8","volume":"37","author":"PT Petersen","year":"2018","unstructured":"Petersen PT, Egelund GB, Jensen AV, Andersen SB, Pedersen MF, Rohde G, et al. Associations between biomarkers at discharge and co-morbidities and risk of readmission after community-acquired pneumonia: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2018;37(6):1\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2117_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1086\/526526","volume":"46","author":"H Jasti","year":"2008","unstructured":"Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis. 2008;46:550\u20136.","journal-title":"Clin Infect Dis"},{"key":"2117_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cid\/cit254","volume":"57","author":"AF Shorr","year":"2013","unstructured":"Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, et al. Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis. 2013;57:362\u20137.","journal-title":"Clin Infect Dis"},{"key":"2117_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2334-14-61","volume":"14","author":"ST Micek","year":"2014","unstructured":"Micek ST, Lang A, Fuller BM, Hampton NB, Kollef MH. Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department. BMC Infect Dis. 2014;14:61.","journal-title":"BMC Infect Dis"},{"key":"2117_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","volume":"275","author":"MJ Fine","year":"1996","unstructured":"Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134\u201341.","journal-title":"JAMA"},{"key":"2117_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7326\/0003-4819-142-3-200502010-00006","volume":"142","author":"J Carratala","year":"2005","unstructured":"Carratala J, Fern\u00e1ndez-Sab\u00e9 N, Ortega L, Castellsagu\u00e9 X, Ros\u00f3n B, Dorca J, et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med. 2005;142:165\u201372.","journal-title":"Ann Intern Med"},{"key":"2117_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377\u201382.","journal-title":"Thorax"},{"key":"2117_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.rmed.2013.04.003","volume":"107","author":"FW Arnold","year":"2013","unstructured":"Arnold FW, Wiemken TL, Peyrani P, Ramirez JA, Brock GN. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the community-acquired pneumonia organization (CAPO) international cohort study. Respir Med. 2013;107:1101\u201311.","journal-title":"Respir Med"},{"key":"2117_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1378\/chest.11-2393","volume":"142","author":"ML Metersky","year":"2012","unstructured":"Metersky ML, Waterer G, Nsa W, Bratzler DW. Predictors of in-hospital vs postdischarge mortality in pneumonia. Chest. 2012;142:476\u201381.","journal-title":"Chest"},{"key":"2117_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/archinte.159.9.970","volume":"159","author":"MJ Fine","year":"1999","unstructured":"Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team (PORT) cohort study. Arch Intern Med. 1999;159:970\u201380.","journal-title":"Arch Intern Med"},{"key":"2117_CR22","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jama.2012.384","volume":"307","author":"PK Lindenauer","year":"2012","unstructured":"Lindenauer PK, Lagu T, Shieh M-S, Pekow PS, Rothberg MB. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003\u20132009. JAMA. 2012;307:1405\u201313.","journal-title":"JAMA"},{"key":"2117_CR23","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cid\/cix647","volume":"65","author":"JA Ramirez","year":"2017","unstructured":"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, et al. Adults hospitalized with pneumonia in the united states: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65:1806\u201312.","journal-title":"Clin Infect Dis"},{"key":"2117_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1469-0691.2010.03296.x","volume":"17","author":"AHW Bruns","year":"2011","unstructured":"Bruns AHW, Oosterheert JJ, Cucciolillo MC, El Moussaoui R, Groenwold RHH, Prins JM, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect. 2011;17:763\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"2117_CR25","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1001\/archinte.159.14.1550","volume":"159","author":"I Koivula","year":"1999","unstructured":"Koivula I, St\u00e9n M, M\u00e4kel\u00e4 P. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med. 1999;159:1550\u20135.","journal-title":"Arch Intern Med"},{"key":"2117_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0140-6736(93)91887-R","volume":"342","author":"FL Brancati","year":"1993","unstructured":"Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man\u2019s friend? Two-year prognosis after community-acquired pneumonia. Lancet. 1993;342:30\u20133.","journal-title":"Lancet"},{"key":"2117_CR27","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1086\/379712","volume":"37","author":"EM Mortensen","year":"2003","unstructured":"Mortensen EM, Kapoor WN, Chang C-CH, Fine MJ. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis. 2003;37:1617\u201324.","journal-title":"Clin Infect Dis"},{"key":"2117_CR28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","volume":"177","author":"S Yende","year":"2008","unstructured":"Yende S, D\u2019Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008;177:1242\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MD.0b013e318190f444","volume":"87","author":"J Johnstone","year":"2008","unstructured":"Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine. 2008;87:329\u201334.","journal-title":"Medicine"},{"key":"2117_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s15010-004-3107-z","volume":"32","author":"T Welte","year":"2004","unstructured":"Welte T, Suttorp N, Marre R. CAPNETZ\u2014community-acquired pneumonia competence network. Infection. 2004;32:234\u20138.","journal-title":"Infection"},{"key":"2117_CR31","unstructured":"CAPNETZ. https:\/\/www.capnetz.de\/html\/capnetz\/lccs. Accessed 29 Nov 2017."},{"key":"2117_CR32","unstructured":"pedCAPNETZ. http:\/\/www.capnetz.de\/html\/pedcapnetz\/project. Accessed 18 May 2022."},{"issue":"3","key":"2117_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.chest.2019.10.006","volume":"157","author":"C Forstner","year":"2019","unstructured":"Forstner C, Patchev V, Rohde G, Rupp J, Witzenrath M, Welte T, et al. Rate and predictors of bacteremia in afebrile community-acquired pneumonia. Chest. 2019;157(3):529\u201339.","journal-title":"Chest"},{"key":"2117_CR34","first-page":"442","volume":"73","author":"MN Lutfiyya","year":"2006","unstructured":"Lutfiyya MN, Henley E, Chang LF, Reyburn SW. Diagnosis and treatment of community-acquired pneumonia. AFP. 2006;73:442\u201350.","journal-title":"AFP"},{"key":"2117_CR35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/infdis\/jiv323","volume":"213","author":"WH Self","year":"2016","unstructured":"Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis. 2016;213:584\u201391.","journal-title":"J Infect Dis"},{"key":"2117_CR36","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cmi.2018.12.037","volume":"25","author":"V Prendki","year":"2019","unstructured":"Prendki V, Huttner B, Marti C, Mamin A, Fubini PE, Meynet MP, et al. Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort study. Clin Microbiol Infect. 2019;25:1114\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"2117_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ccm.2011.05.011","volume":"32","author":"TM File Jr","year":"2011","unstructured":"File TM Jr. New diagnostic tests for pneumonia: what is their role in clinical practice? Clin Chest Med. 2011;32:417\u201330.","journal-title":"Clin Chest Med"},{"key":"2117_CR38","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1183\/13993003.01144-2016","volume":"48","author":"A Torres","year":"2016","unstructured":"Torres A, Lee N, Cilloniz C, Vila J, der Eerden MV. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J. 2016;48:1764\u201378.","journal-title":"Eur Respir J"},{"key":"2117_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cid\/cit734","volume":"58","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis. 2014;58:330\u20139.","journal-title":"Clin Infect Dis"},{"key":"2117_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/thoraxjnl-2013-203384","volume":"68","author":"S Aliberti","year":"2013","unstructured":"Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013;68:997\u20139.","journal-title":"Thorax"},{"key":"2117_CR41","doi-asserted-by":"publisher","first-page":"1602086","DOI":"10.1183\/13993003.02086-2016","volume":"49","author":"R Faner","year":"2017","unstructured":"Faner R, Sibila O, Agust\u00ed A, Bernasconi E, Chalmers JD, Huffnagle GB, et al. The microbiome in respiratory medicine: current challenges and future perspectives. Eur Respir J. 2017;49:1602086.","journal-title":"Eur Respir J"},{"key":"2117_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41587-019-0156-5","volume":"37","author":"T Charalampous","year":"2019","unstructured":"Charalampous T, Kay GL, Richardson H, Aydin A, Baldan R, Jeanes C, et al. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection. Nat Biotechnol. 2019;37:783\u201392.","journal-title":"Nat Biotechnol"},{"key":"2117_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1183\/09031936.01.00213501","volume":"18","author":"T Franquet","year":"2001","unstructured":"Franquet T. Imaging of pneumonia: trends and algorithms. Eur Respir J. 2001;18:196\u2013208.","journal-title":"Eur Respir J"},{"key":"2117_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ajem.2012.08.041","volume":"31","author":"WH Self","year":"2013","unstructured":"Self WH, Courtney DM, McNaughton CD, Wunderink RG, Kline JA. High discordance of chest X-ray and CT for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia. Am J Emerg Med. 2013;31:401\u20135.","journal-title":"Am J Emerg Med"},{"key":"2117_CR45","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1164\/rccm.201501-0017OC","volume":"192","author":"Y-E Claessens","year":"2015","unstructured":"Claessens Y-E, Debray M-P, Tubach F, Brun A-L, Rammaert B, Hausfater P, et al. Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med. 2015;192:974\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2169\/internalmedicine.55.5556","volume":"55","author":"T Haga","year":"2016","unstructured":"Haga T, Fukuoka M, Morita M, Cho K, Tatsumi K. Computed tomography for the diagnosis and evaluation of the severity of community-acquired pneumonia in the elderly. Intern Med. 2016;55:437\u201341.","journal-title":"Intern Med"},{"key":"2117_CR47","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ajem.2015.01.035","volume":"33","author":"P Nazerian","year":"2015","unstructured":"Nazerian P, Volpicelli G, Vanni S, Gigli C, Betti L, Bartolucci M, et al. Accuracy of lung ultrasound for the diagnosis of consolidations when compared to chest computed tomography. Am J Emerg Med. 2015;33:620\u20135.","journal-title":"Am J Emerg Med"},{"key":"2117_CR48","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1378\/chest.12-0364","volume":"142","author":"A Reissig","year":"2012","unstructured":"Reissig A, Copetti R, Mathis G, Mempel C, Schuler A, Zechner P, et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest. 2012;142:965\u201372.","journal-title":"Chest"},{"key":"2117_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/RTI.0000000000000524","author":"S Simpson","year":"2020","unstructured":"Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. J Thorac Imaging. 2020. https:\/\/doi.org\/10.1097\/RTI.0000000000000524.","journal-title":"J Thorac Imaging"},{"key":"2117_CR50","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.chest.2017.08.028","volume":"152","author":"AM Llamas-\u00c1lvarez","year":"2017","unstructured":"Llamas-\u00c1lvarez AM, Tenza-Lozano EM, Latour-P\u00e9rez J. Diaphragm and lung ultrasound to predict weaning outcome: systematic review and meta-analysis. Chest. 2017;152:1140\u201350.","journal-title":"Chest"},{"key":"2117_CR51","doi-asserted-by":"publisher","first-page":"1700434","DOI":"10.1183\/13993003.00434-2017","volume":"50","author":"M Moore","year":"2017","unstructured":"Moore M, Stuart B, Little P, Smith S, Thompson MJ, Knox K, et al. Predictors of pneumonia in lower respiratory tract infections: 3C prospective cough complication cohort study. Eur Respir J. 2017;50:1700434.","journal-title":"Eur Respir J"},{"key":"2117_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2450","author":"SF van Vugt","year":"2013","unstructured":"van Vugt SF, Broekhuizen BDL, Lammens C, Zuithoff NPA, de Jong PA, Coenen S, et al. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ. 2013. https:\/\/doi.org\/10.1136\/bmj.f2450.","journal-title":"BMJ"},{"key":"2117_CR53","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00134-007-0895-5","volume":"33","author":"S Kr\u00fcger","year":"2007","unstructured":"Kr\u00fcger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, et al. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia. Intensive Care Med. 2007;33:2069\u201378.","journal-title":"Intensive Care Med"},{"key":"2117_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2334-12-90","volume":"12","author":"M Kolditz","year":"2012","unstructured":"Kolditz M, H\u00f6ffken G, Martus P, Rohde G, Sch\u00fctte H, Bals R, et al. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. BMC Infect Dis. 2012;12:90.","journal-title":"BMC Infect Dis"},{"key":"2117_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3397","volume":"344","author":"PM Lepper","year":"2012","unstructured":"Lepper PM, Ott S, Nuesch E, von Eynatten M, Schumann C, Pletz MW, et al. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ. 2012;344: e3397.","journal-title":"BMJ"},{"key":"2117_CR56","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1513\/AnnalsATS.201901-007OC","volume":"16","author":"AV Jensen","year":"2019","unstructured":"Jensen AV, Baunb\u00e6kEgelund G, Bang Andersen S, Petersen PT, Benfield T, Witzenrath M, et al. The glycemic gap and 90-day mortality in community-acquired pneumonia. A prospective cohort study. Ann ATS. 2019;16:1518\u201326.","journal-title":"Ann ATS"},{"key":"2117_CR57","doi-asserted-by":"publisher","first-page":"1701389","DOI":"10.1183\/13993003.01389-2017","volume":"51","author":"F Ebrahimi","year":"2018","unstructured":"Ebrahimi F, Giaglis S, Hahn S, Blum CA, Baumgartner C, Kutz A, et al. Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial. Eur Respir J. 2018;51:1701389.","journal-title":"Eur Respir J"},{"key":"2117_CR58","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1164\/rccm.201003-0415OC","volume":"182","author":"S Kr\u00fcger","year":"2010","unstructured":"Kr\u00fcger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia. Am J Respir Crit Care Med. 2010;182:1426\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR59","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1164\/rccm.201708-1733OC","volume":"198","author":"B Gutbier","year":"2018","unstructured":"Gutbier B, Neuhau\u00df A-K, Reppe K, Ehrler C, Santel A, Kaufmann J, et al. Prognostic and pathogenic role of angiopoietin-1 and -2 in pneumonia. Am J Respir Crit Care Med. 2018;198:220\u201331.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR60","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/ijms20082004","volume":"20","author":"M Karakioulaki","year":"2019","unstructured":"Karakioulaki M, Stolz D. Biomarkers in pneumonia\u2014beyond procalcitonin. Int J Mol Sci. 2019;20:2004.","journal-title":"Int J Mol Sci"},{"key":"2117_CR61","doi-asserted-by":"publisher","first-page":"7028267","DOI":"10.1155\/2018\/7028267","volume":"2018","author":"M Holub","year":"2018","unstructured":"Holub M, D\u017eupov\u00e1 O, R\u016f\u017ekov\u00e1 M, Str\u00e1n\u00edkov\u00e1 A, Bart\u00e1kov\u00e1 E, M\u00e1ca J, et al. Selected biomarkers correlate with the origin and severity of sepsis. Mediat Inflamm. 2018;2018:7028267.","journal-title":"Mediat Inflamm"},{"issue":"5","key":"2117_CR62","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/resp.12996","volume":"22","author":"SMT Vestjens","year":"2017","unstructured":"Vestjens SMT, Spoorenberg SMC, Rijkers GT, Grutters JC, Ten Berg JM, Noordzij PG, et al. High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia. Respirology. 2017;22(5):1000\u20136.","journal-title":"Respirology"},{"key":"2117_CR63","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1513\/AnnalsATS.201804-286OC","volume":"16","author":"JF Frencken","year":"2019","unstructured":"Frencken JF, van Baal L, Kappen TH, Donker DW, Horn J, van der Poll T, et al. Myocardial injury in critically ill patients with community-acquired pneumonia. A cohort study. Ann Am Thorac Soc. 2019;16:606\u201312.","journal-title":"Ann Am Thorac Soc"},{"key":"2117_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191750","volume":"13","author":"VF Corrales-Medina","year":"2018","unstructured":"Corrales-Medina VF, Dwivedi G, Taljaard M, Petrcich W, Lima JA, Yende S, et al. Coronary artery calcium before and after hospitalization with pneumonia: the MESA study. PLoS ONE. 2018;13: e0191750.","journal-title":"PLoS ONE"},{"key":"2117_CR65","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1007\/s001340051129","volume":"26","author":"WJ Kox","year":"2000","unstructured":"Kox WJ, Volk T, Kox SN, Volk H-D. Immunomodulatory therapies in sepsis. Intensive Care Med. 2000;26:S124\u20138.","journal-title":"Intensive Care Med"},{"key":"2117_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0032-1315637","volume":"33","author":"G Waterer","year":"2012","unstructured":"Waterer G. Community-acquired pneumonia: genomics, epigenomics, transcriptomics, proteomics, and metabolomics. Semin Respir Crit Care Med. 2012;33:257\u201365.","journal-title":"Semin Respir Crit Care Med"},{"key":"2117_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/joim.12349","volume":"278","author":"M Kolditz","year":"2015","unstructured":"Kolditz M, Ewig S, Sch\u00fctte H, Suttorp N, Welte T, Rohde G. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med. 2015;278:193\u2013202.","journal-title":"J Intern Med"},{"key":"2117_CR68","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/thoraxjnl-2015-206881","volume":"70","author":"WS Lim","year":"2015","unstructured":"Lim WS, Smith DL, Wise MP, Welham SA. British thoracic society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together. Thorax. 2015;70:698\u2013700.","journal-title":"Thorax"},{"key":"2117_CR69","doi-asserted-by":"publisher","first-page":"306.e1","DOI":"10.1016\/j.cmi.2017.07.007","volume":"24","author":"FS Frenzen","year":"2018","unstructured":"Frenzen FS, Kutschan U, Meiswinkel N, Schulte-Hubbert B, Ewig S, Kolditz M. Admission lactate predicts poor prognosis independently of the CRB\/CURB-65 scores in community-acquired pneumonia. Clin Microbiol Infect. 2018;24:306.e1-306.e6.","journal-title":"Clin Microbiol Infect"},{"key":"2117_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.rmed.2016.10.015","volume":"121","author":"M Kolditz","year":"2016","unstructured":"Kolditz M, Tesch F, Mocke L, H\u00f6ffken G, Ewig S, Schmitt J. Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study. Respir Med. 2016;121:32\u20138.","journal-title":"Respir Med"},{"key":"2117_CR71","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"2117_CR72","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00134-016-4517-y","volume":"42","author":"M Kolditz","year":"2016","unstructured":"Kolditz M, Scherag A, Rohde G, Ewig S, Welte T, Pletz M, et al. Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia. Intensive Care Med. 2016;42:2108\u201310.","journal-title":"Intensive Care Med"},{"key":"2117_CR73","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012634","volume":"97","author":"J Jiang","year":"2018","unstructured":"Jiang J, Yang J, Jin Y, Cao J, Lu Y. Role of qSOFA in predicting mortality of pneumonia. Medicine (Baltimore). 2018;97: e12634.","journal-title":"Medicine (Baltimore)"},{"key":"2117_CR74","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199:980\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR75","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.annemergmed.2018.11.036","volume":"73","author":"RJ Delahanty","year":"2019","unstructured":"Delahanty RJ, Alvarez J, Flynn LM, Sherwin RL, Jones SS. Development and evaluation of a machine learning model for the early identification of patients at risk for sepsis. Ann Emerg Med. 2019;73:334\u201344.","journal-title":"Ann Emerg Med"},{"key":"2117_CR76","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1001\/jama.2018.19232","volume":"320","author":"RK Wadhera","year":"2018","unstructured":"Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW. Association of the hospital readmissions reduction program with mortality among medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA. 2018;320:2542\u201352.","journal-title":"JAMA"},{"key":"2117_CR77","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cmi.2019.02.022","volume":"25","author":"S Ewig","year":"2019","unstructured":"Ewig S, Kolditz M, Pletz MW, Chalmers J. Healthcare-associated pneumonia: is there any reason to continue to utilize this label in 2019? Clin Microbiol Infect. 2019;25:1173\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"2117_CR78","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jama.2016.0115","volume":"315","author":"JS Lee","year":"2016","unstructured":"Lee JS, Giesler DL, Gellad WF, Fine MJ. Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review. JAMA. 2016;315:593\u2013602.","journal-title":"JAMA"},{"key":"2117_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002109.pub4","author":"S Pakhale","year":"2014","unstructured":"Pakhale S, Mulpuru S, Verheij TJ, Kochen MM, Rohde GG, Bjerre LM. Antibiotics for community-acquired pneumonia in adult outpatients. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.CD002109.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"2117_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MCP.0000000000000557","volume":"25","author":"MP Schreiber","year":"2019","unstructured":"Schreiber MP, Shorr AF. Inhaled antibiotics for the treatment of pneumonia. Curr Opin Pulm Med. 2019;25:289\u201393.","journal-title":"Curr Opin Pulm Med"},{"key":"2117_CR81","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/jim-2018-000712","volume":"66","author":"D Dandachi","year":"2018","unstructured":"Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. J Investig Med. 2018;66:957\u201365.","journal-title":"J Investig Med"},{"key":"2117_CR82","doi-asserted-by":"publisher","first-page":"2100048","DOI":"10.1183\/13993003.00048-2021","volume":"57","author":"JD Chalmers","year":"2021","unstructured":"Chalmers JD, Crichton ML, Goeminne PC, Cao B, Humbert M, Shteinberg M, et al. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J. 2021;57:2100048.","journal-title":"Eur Respir J"},{"key":"2117_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-03379-5","author":"F Graham","year":"2021","unstructured":"Graham F. Daily briefing: Pfizer\u2019s COVID pill looks promising. Nature. 2021. https:\/\/doi.org\/10.1038\/d41586-021-03379-5.","journal-title":"Nature"},{"key":"2117_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/QCO.0000000000000347","volume":"30","author":"I Martin-Loeches","year":"2017","unstructured":"Martin-Loeches I, van Someren GF, Schultz MJ. Bacterial pneumonia as an influenza complication. Curr Opin Infect Dis. 2017;30:201\u20137.","journal-title":"Curr Opin Infect Dis"},{"key":"2117_CR85","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/toxins11120734","volume":"11","author":"S Deinhardt-Emmer","year":"2019","unstructured":"Deinhardt-Emmer S, Haupt KF, Garcia-Moreno M, Geraci J, Forstner C, Pletz M, et al. Staphylococcus aureus pneumonia: preceding influenza infection paves the way for low-virulent strains. Toxins (Basel). 2019;11:734.","journal-title":"Toxins (Basel)"},{"key":"2117_CR86","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MCC.0000000000000435","volume":"23","author":"K Cawcutt","year":"2017","unstructured":"Cawcutt K, Kalil AC. Pneumonia with bacterial and viral coinfection. Curr Opin Crit Care. 2017;23:385\u201390.","journal-title":"Curr Opin Crit Care"},{"key":"2117_CR87","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","volume":"26","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26:1622\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"2117_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"key":"2117_CR89","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","volume":"7","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol. 2016;7:693.","journal-title":"Front Microbiol"},{"key":"2117_CR90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dkp160","volume":"64","author":"O Peuchant","year":"2009","unstructured":"Peuchant O, M\u00e9nard A, Renaudin H, Morozumi M, Ubukata K, B\u00e9b\u00e9ar CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64:52\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2117_CR91","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1128\/JCM.02597-14","volume":"53","author":"MH Diaz","year":"2015","unstructured":"Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53:124\u201330.","journal-title":"J Clin Microbiol"},{"key":"2117_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1430-2","volume":"20","author":"M Bassetti","year":"2016","unstructured":"Bassetti M, Welte T, Wunderink RG. Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair? Crit Care. 2016;20:1\u20139.","journal-title":"Crit Care"},{"key":"2117_CR93","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMp1905589","volume":"381","author":"TB Nielsen","year":"2019","unstructured":"Nielsen TB, Brass EP, Gilbert DN, Bartlett JG, Spellberg B. Sustainable discovery and development of antibiotics\u2014is a nonprofit approach the future? N Engl J Med. 2019;381:503\u20135.","journal-title":"N Engl J Med"},{"key":"2117_CR94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11908-017-0565-x","volume":"19","author":"F Arancibia","year":"2017","unstructured":"Arancibia F, Ruiz M. Risk factors for drug-resistant cap in immunocompetent patients. Curr Infect Dis Rep. 2017;19:11.","journal-title":"Curr Infect Dis Rep"},{"key":"2117_CR95","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1055\/s-0036-1593538","volume":"37","author":"O Sibila","year":"2016","unstructured":"Sibila O, Rodrigo-Troyano A, Torres A. Nonantibiotic adjunctive therapies for community-acquired pneumonia (corticosteroids and beyond): where are we with them? Semin Respir Crit Care Med. 2016;37:913\u201322.","journal-title":"Semin Respir Crit Care Med"},{"key":"2117_CR96","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/01.RES.0000036603.61868.F9","volume":"91","author":"H Stefan","year":"2002","unstructured":"Stefan H, Martin W, Bernd S, Andreas H, Mathias K, Matthias K, et al. Adrenomedullin reduces endothelial hyperpermeability. Circ Res. 2002;91:618\u201325.","journal-title":"Circ Res"},{"key":"2117_CR97","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1183\/13993003.01329-2016","volume":"48","author":"JD Chalmers","year":"2016","unstructured":"Chalmers JD. Corticosteroids for community-acquired pneumonia: a critical view of the evidence. Eur Respir J. 2016;48:984\u20136.","journal-title":"Eur Respir J"},{"key":"2117_CR98","first-page":"1","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19. JAMA. 2020;324:1\u201313.","journal-title":"JAMA"},{"key":"2117_CR99","unstructured":"COVID-19: management in hospitalized adults\u2014UpToDate. https:\/\/www.uptodate.com\/contents\/covid-19-management-in-hospitalized-adults?search=Interleukin%201%20antagonists%20covid&sectionRank=1&usage_type=default&anchor=H3001451751&source=machineLearning&selectedTitle=3~150&display_rank=3#H3001451751. Accessed 6 Jan 2022."},{"key":"2117_CR100","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","volume":"9","author":"VC Marconi","year":"2021","unstructured":"Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, et al. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Lancet Respir Med. 2021;9:1407\u201318.","journal-title":"Lancet Respir Med"},{"key":"2117_CR101","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2101643","volume":"385","author":"PO Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;385:406\u201315.","journal-title":"N Engl J Med"},{"key":"2117_CR102","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","volume":"27","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021;27:1752\u201360.","journal-title":"Nat Med"},{"key":"2117_CR103","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jama.2021.9508","volume":"326","author":"R Caricchio","year":"2021","unstructured":"Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, et al. Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial. JAMA. 2021;326:230\u20139.","journal-title":"JAMA"},{"key":"2117_CR104","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S2213-2600(20)30556-7","volume":"9","author":"PL Tharaux","year":"2021","unstructured":"Tharaux PL, Pialoux G, Pavot A, Mariette X, Hermine O, Resche-Rigon M, Porcher R, Ravaud P, Bureau S, Dougados M, Tibi A. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Lancet Respir Med. 2021;9:295\u2013304.","journal-title":"Lancet Respir Med"},{"key":"2117_CR105","doi-asserted-by":"publisher","unstructured":"Aliberti S, Chalmers JD, Pletz MW. Anti-infectives and the lung. 2017. https:\/\/doi.org\/10.1183\/2312508X.erm7517. Accessed 25 May 2018.","DOI":"10.1183\/2312508X.erm7517"},{"key":"2117_CR106","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590\u2013615.","journal-title":"Clin Microbiol Rev"},{"key":"2117_CR107","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","volume":"372","author":"DF Postma","year":"2015","unstructured":"Postma DF, van Werkhoven CH, van Elden LJR, Thijsen SFT, Hoepelman AIM, Kluytmans JAJW, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372:1312\u201323.","journal-title":"N Engl J Med"},{"key":"2117_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54922-4","volume":"9","author":"A Ito","year":"2019","unstructured":"Ito A, Ishida T, Tachibana H, Tokumasu H, Yamazaki A, Washio Y. Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis. Sci Rep. 2019;9:1\u20138.","journal-title":"Sci Rep"},{"key":"2117_CR109","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/resp.13232","volume":"23","author":"J Okumura","year":"2018","unstructured":"Okumura J, Shindo Y, Takahashi K, Sano M, Sugino Y, Yagi T, et al. Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: impact of \u03b2-lactam plus macrolide combination therapy. Respirology. 2018;23:526\u201334.","journal-title":"Respirology"},{"key":"2117_CR110","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0032-1315643","volume":"33","author":"RG Wunderink","year":"2012","unstructured":"Wunderink RG, Mandell L. Adjunctive therapy in community-acquired pneumonia. Semin Respir Crit Care Med. 2012;33:311\u20138.","journal-title":"Semin Respir Crit Care Med"},{"key":"2117_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3630-7","volume":"19","author":"DF Postma","year":"2019","unstructured":"Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial. BMC Infect Dis. 2019;19:1\u201312.","journal-title":"BMC Infect Dis"},{"key":"2117_CR112","doi-asserted-by":"publisher","first-page":"1900824","DOI":"10.1183\/13993003.00824-2019","volume":"54","author":"R K\u00f6nig","year":"2019","unstructured":"K\u00f6nig R, Cao X, Oswald M, Forstner C, Rohde G, Rupp J, et al. Macrolide combination therapy for hospitalised CAP patients? An individualised approach supported by machine learning. Eur Respir J. 2019;54:1900824.","journal-title":"Eur Respir J"},{"key":"2117_CR113","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","volume":"44","author":"T Welte","year":"2018","unstructured":"Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Singer M, et al. Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study). Intensive Care Med. 2018;44:438\u201348.","journal-title":"Intensive Care Med"},{"key":"2117_CR114","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.rmed.2013.09.005","volume":"107","author":"MC de la Torre","year":"2013","unstructured":"de la Torre MC, Bol\u00edbar I, Vendrell M, de Gracia J, Vendrell E, Rodrigo MJ, et al. Serum immunoglobulins in the infected and convalescent phases in community-acquired pneumonia. Respir Med. 2013;107:2038\u201345.","journal-title":"Respir Med"},{"issue":"1","key":"2117_CR115","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2016-000152","volume":"3","author":"MC de la Torre","year":"2016","unstructured":"de la Torre MC, Tor\u00e1n P, Serra-Prat M, Palomera E, G\u00fcell E, Vendrell E, et al. Serum levels of immunoglobulins and severity of community-acquired pneumonia. BMJ Open Respir Res. 2016;3(1): e000152.","journal-title":"BMJ Open Respir Res"},{"key":"2117_CR116","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/v11030295","volume":"11","author":"S-M Wienhold","year":"2019","unstructured":"Wienhold S-M, Lienau J, Witzenrath M. Towards inhaled phage therapy in western Europe. Viruses. 2019;11:295.","journal-title":"Viruses"},{"key":"2117_CR117","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","volume":"385","author":"M Dougan","year":"2021","unstructured":"Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, et al. Bamlanivimab plus etesevimab in mild or moderate Covid-19. N Engl J Med. 2021;385:1382\u201392.","journal-title":"N Engl J Med"},{"key":"2117_CR118","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.15.21258542v1","author":"PW Horby","year":"2021","unstructured":"Group RC, Horby PW, Mafham M, Peto L, Campbell M, Pessoa-Amorim G, et al. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021. https:\/\/doi.org\/10.1101\/2021.06.15.21258542v1.","journal-title":"Lancet"},{"key":"2117_CR119","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1183\/09031936.00133510","volume":"38","author":"A Tessmer","year":"2011","unstructured":"Tessmer A, Welte T, Schmidt-Ott R, Eberle S, Barten G, Suttorp N, et al. Influenza vaccination is associated with reduced severity of community-acquired pneumonia. Eur Respir J. 2011;38:147\u201353.","journal-title":"Eur Respir J"},{"key":"2117_CR120","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2013.279206","volume":"310","author":"JA Udell","year":"2013","unstructured":"Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310:1711\u201320.","journal-title":"JAMA"},{"key":"2117_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2017.07.020","volume":"193","author":"M-H Chiang","year":"2017","unstructured":"Chiang M-H, Wu H-H, Shih C-J, Chen Y-T, Kuo S-C, Chen T-L. Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients. Am Heart J. 2017;193:1\u20137.","journal-title":"Am Heart J"},{"key":"2117_CR122","first-page":"1476","volume":"144","author":"O Fr\u00f6bert","year":"2021","unstructured":"Fr\u00f6bert O, G\u00f6tberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial circulation. Am Heart Assoc. 2021;144:1476\u201384.","journal-title":"Am Heart Assoc"},{"key":"2117_CR123","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7657.1","author":"MW Pletz","year":"2016","unstructured":"Pletz MW, Rohde GG, Welte T, Kolditz M, Ott S. Advances in the prevention, management, and treatment of community-acquired pneumonia. Research. 2016. https:\/\/doi.org\/10.12688\/f1000research.7657.1.","journal-title":"Research"},{"key":"2117_CR124","first-page":"1336","volume":"323","author":"J Abbasi","year":"2020","unstructured":"Abbasi J. FLU-v, a universal flu vaccine candidate, advances in trial. JAMA. 2020;323:1336.","journal-title":"JAMA"},{"key":"2117_CR125","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7326\/M19-0735","volume":"172","author":"O Pleguezuelos","year":"2020","unstructured":"Pleguezuelos O, Dille J, de Groen S, Oftung F, Niesters HGM, Islam MA, et al. Immunogenicity, safety, and efficacy of a standalone universal influenza vaccine, FLU-v, in healthy adults. Ann Intern Med. 2020;172:453\u201362.","journal-title":"Ann Intern Med"},{"key":"2117_CR126","first-page":"CD000422","volume":"2013","author":"S Moberley","year":"2013","unstructured":"Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;2013:CD000422.","journal-title":"Cochrane Database Syst Rev"},{"key":"2117_CR127","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S1473-3099(17)30049-X","volume":"17","author":"M Suzuki","year":"2017","unstructured":"Suzuki M, Dhoubhadel BG, Ishifuji T, Yasunami M, Yaegashi M, Asoh N, et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis. 2017;17:313\u201321.","journal-title":"Lancet Infect Dis"},{"key":"2117_CR128","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","volume":"355","author":"N French","year":"2000","unstructured":"French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, et al. 23\u2013valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet. 2000;355:2106\u201311.","journal-title":"Lancet"},{"key":"2117_CR129","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32\u201341.","journal-title":"J Infect Dis"},{"key":"2117_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169370","volume":"12","author":"O Makarewicz","year":"2017","unstructured":"Makarewicz O, Lucas M, Brandt C, Herrmann L, Albersmeier A, R\u00fcckert C, et al. Whole genome sequencing of 39 invasive Streptococcus pneumoniae sequence type 199 isolates revealed switches from serotype 19A to 15B. PLoS ONE. 2017;12: e0169370.","journal-title":"PLoS ONE"},{"key":"2117_CR131","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.vaccine.2016.03.052","volume":"34","author":"MW Pletz","year":"2016","unstructured":"Pletz MW, Ewig S, Rohde G, Schuette H, Rupp J, Welte T, et al. Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay. Vaccine. 2016;34:2342\u20138.","journal-title":"Vaccine"},{"key":"2117_CR132","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1183\/09031936.00183614","volume":"45","author":"C Rodrigo","year":"2015","unstructured":"Rodrigo C, Bewick T, Sheppard C, Greenwood S, Mckeever TM, Trotter CL, et al. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. Eur Respir J. 2015;45:1632\u201341.","journal-title":"Eur Respir J"},{"issue":"5","key":"2117_CR133","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.vaccine.2019.11.026","volume":"38","author":"C Forstner","year":"2019","unstructured":"Forstner C, Kolditz M, Kesselmeier M, Ewig S, Rohde G, Barten-Neiner G, et al. Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia. Vaccine. 2019;38(5):1129\u201336.","journal-title":"Vaccine"},{"key":"2117_CR134","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1016\/j.vaccine.2019.05.003","volume":"37","author":"JJ LeBlanc","year":"2019","unstructured":"LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, et al. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: a study from the serious outcomes surveillance (SOS) network of the Canadian immunization research network (CIRN). Vaccine. 2019;37:5466\u201373.","journal-title":"Vaccine"},{"key":"2117_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007438","volume":"14","author":"T Azarian","year":"2018","unstructured":"Azarian T, Mitchell PK, Georgieva M, Thompson CM, Ghouila A, Pollard AJ, et al. Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci. PLoS Pathog. 2018;14: e1007438.","journal-title":"PLoS Pathog"},{"key":"2117_CR136","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijantimicag.2008.01.021","volume":"32","author":"MW Pletz","year":"2008","unstructured":"Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents. 2008;32:199\u2013206.","journal-title":"Int J Antimicrob Agents"},{"key":"2117_CR137","unstructured":"Pletz M. Sequential versus simultaneous vaccination with pneumococcal conjugate vaccine (prevenar 13) and pneumococcal polysaccharide vaccine (pneumovax 23) in elderly: immunological memory and antibody levels. clinicaltrials.gov; 2021. Report No. NCT02637583. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02637583."},{"key":"2117_CR138","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/jgid.jgid_88_17","volume":"10","author":"C Green","year":"2018","unstructured":"Green C, Moore CA, Mahajan A, Bajaj K. A simple approach to pneumococcal vaccination in adults. J Glob Infect Dis. 2018;10:159\u201362.","journal-title":"J Glob Infect Dis"},{"key":"2117_CR139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3934\/publichealth.2020004","volume":"7","author":"G Oligbu","year":"2020","unstructured":"Oligbu G. Higher valent pneumococcal conjugate vaccines: is it a roller coaster? AIMS Public Health. 2020;7:29\u201332.","journal-title":"AIMS Public Health"},{"key":"2117_CR140","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3390\/vaccines7010009","volume":"7","author":"T Lagousi","year":"2019","unstructured":"Lagousi T, Basdeki P, Routsias J, Spoulou V. Novel protein-based pneumococcal vaccines: assessing the use of distinct protein fragments instead of full-length proteins as vaccine antigens. Vaccines (Basel). 2019;7:E9.","journal-title":"Vaccines (Basel)"},{"key":"2117_CR141","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000504477","volume":"43","author":"CA Green","year":"2020","unstructured":"Green CA, Drysdale SB, Pollard AJ, Sande CJ. Vaccination against respiratory syncytial virus. Vaccines Older Adults Curr Pract Future Oppor. 2020;43:182\u201392.","journal-title":"Vaccines Older Adults Curr Pract Future Oppor"},{"key":"2117_CR142","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/374604","volume":"187","author":"EM Ponnuraj","year":"2003","unstructured":"Ponnuraj EM, Springer J, Hayward AR, Wilson H, Simoes EAF. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the bonnet monkey model. J Infect Dis. 2003;187:1257\u201363.","journal-title":"J Infect Dis"},{"key":"2117_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bmb\/61.1.1","volume":"61","author":"RJ Boyton","year":"2002","unstructured":"Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection. Br Med Bull. 2002;61:1\u201312.","journal-title":"Br Med Bull"},{"key":"2117_CR144","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2020.04.002","volume":"53","author":"X Sun","year":"2020","unstructured":"Sun X, Wang T, Cai D, Hu Z, Chen J, Liao H, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev. 2020;53:38\u201342.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2117_CR145","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3389\/fimmu.2018.01421","volume":"9","author":"MJ Crane","year":"2018","unstructured":"Crane MJ, Lee KM, FitzGerald ES, Jamieson AM. Surviving deadly lung infections: innate host tolerance mechanisms in the pulmonary system. Front Immunol. 2018;9:1421.","journal-title":"Front Immunol"},{"key":"2117_CR146","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1183\/16000617.0034-2015","volume":"24","author":"H M\u00fcller-Redetzky","year":"2015","unstructured":"M\u00fcller-Redetzky H, Lienau J, Suttorp N, Witzenrath M. Therapeutic strategies in pneumonia: going beyond antibiotics. Eur Respir Rev. 2015;24:516\u201324.","journal-title":"Eur Respir Rev"},{"key":"2117_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep35021","volume":"6","author":"TV Smelaya","year":"2016","unstructured":"Smelaya TV, Belopolskaya OB, Smirnova SV, Kuzovlev AN, Moroz VV, Golubev AM, et al. Genetic dissection of host immune response in pneumonia development and progression. Sci Rep. 2016;6:1\u201312.","journal-title":"Sci Rep"},{"key":"2117_CR148","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gene.2018.08.080","volume":"679","author":"X Wang","year":"2018","unstructured":"Wang X, Guo J, Wang Y, Xiao Y, Wang L, Hua S. Genetic variants of interferon regulatory factor 5 associated with the risk of community-acquired pneumonia. Gene. 2018;679:73\u201380.","journal-title":"Gene"},{"key":"2117_CR149","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12920-019-0572-x","volume":"12","author":"AT Kloek","year":"2019","unstructured":"Kloek AT, Brouwer MC, van de Beek D. Host genetic variability and pneumococcal disease: a systematic review and meta-analysis. BMC Med Genom. 2019;12:130.","journal-title":"BMC Med Genom"},{"key":"2117_CR150","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1164\/rccm.201701-0104OC","volume":"196","author":"LF Reyes","year":"2017","unstructured":"Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Anzueto A, Babu BL, et al. Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling. Am J Respir Crit Care Med. 2017;196:609\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR151","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MCP.0000000000000584","volume":"25","author":"MC Brack","year":"2019","unstructured":"Brack MC, Lienau J, Kuebler WM, Witzenrath M. Cardiovascular sequelae of pneumonia. Curr Opin Pulm Med. 2019;25:257\u201362.","journal-title":"Curr Opin Pulm Med"},{"key":"2117_CR152","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00020-2015","author":"S Aliberti","year":"2015","unstructured":"Aliberti S, Ramirez J, Cosentini R, Valenti V, Voza A, Rossi P, et al. Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia. ERJ Open Res. 2015. https:\/\/doi.org\/10.1183\/23120541.00020-2015.","journal-title":"ERJ Open Res"},{"key":"2117_CR153","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/cid\/cix703","volume":"65","author":"AV Jensen","year":"2017","unstructured":"Jensen AV, Faurholt-Jepsen D, Egelund GB, Andersen SB, Petersen PT, Benfield T, et al. Undiagnosed diabetes mellitus in community-acquired pneumonia: a prospective cohort study. Clin Infect Dis. 2017;65:2091\u20138.","journal-title":"Clin Infect Dis"},{"key":"2117_CR154","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cir840","volume":"54","author":"S Aliberti","year":"2012","unstructured":"Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis. 2012;54:470\u20138.","journal-title":"Clin Infect Dis"},{"key":"2117_CR155","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/cid\/ciy723","volume":"68","author":"MF Di Pasquale","year":"2019","unstructured":"Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, et al. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. Clin Infect Dis. 2019;68:1482\u201393.","journal-title":"Clin Infect Dis"},{"key":"2117_CR156","first-page":"57","volume":"5","author":"T Scholl","year":"2018","unstructured":"Scholl T, Kiser TH, Vondracek SF. Evaluation of systemic corticosteroids in patients with an acute exacerbation of COPD and a diagnosis of pneumonia. Chronic Obstr Pulm Dis. 2018;5:57\u201365.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2117_CR157","doi-asserted-by":"publisher","first-page":"1601520","DOI":"10.1183\/13993003.01520-2016","volume":"49","author":"J Zugazagoitia","year":"2017","unstructured":"Zugazagoitia J, Molina-Pinelo S, Lopez-Rios F, Paz-Ares L. Biological therapies in nonsmall cell lung cancer. Eur Respir J. 2017;49:1601520.","journal-title":"Eur Respir J"},{"key":"2117_CR158","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ejim.2013.12.001","volume":"25","author":"P Faverio","year":"2014","unstructured":"Faverio P, Aliberti S, Bellelli G, Suigo G, Lonni S, Pesci A, et al. The management of community-acquired pneumonia in the elderly. Eur J Intern Med. 2014;25:312\u20139.","journal-title":"Eur J Intern Med"},{"key":"2117_CR159","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40520-014-0297-9","volume":"27","author":"S Aliberti","year":"2015","unstructured":"Aliberti S, Bellelli G, Belotti M, Morandi A, Messinesi G, Annoni G, et al. Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia. Aging Clin Exp Res. 2015;27:523\u201331.","journal-title":"Aging Clin Exp Res"},{"key":"2117_CR160","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/resp.13233","volume":"23","author":"MI Restrepo","year":"2018","unstructured":"Restrepo MI, Reyes LF. Pneumonia as a cardiovascular disease. Respirology. 2018;23:250\u20139.","journal-title":"Respirology"},{"key":"2117_CR161","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0140-6736(12)61266-5","volume":"381","author":"VF Corrales-Medina","year":"2013","unstructured":"Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet. 2013;381:496\u2013505.","journal-title":"Lancet"},{"key":"2117_CR162","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1164\/rccm.201501-0140OC","volume":"192","author":"DT Eurich","year":"2015","unstructured":"Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Ten-year mortality after community-acquired pneumonia. A prospective cohort. Am J Respir Crit Care Med. 2015;192:597\u2013604.","journal-title":"Am J Respir Crit Care Med"},{"key":"2117_CR163","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j413","volume":"356","author":"DT Eurich","year":"2017","unstructured":"Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. BMJ. 2017;356: j413.","journal-title":"BMJ"},{"key":"2117_CR164","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1183\/13993003.00972-2015","volume":"48","author":"JE Jaw","year":"2016","unstructured":"Jaw JE, Tsuruta M, Oh Y, Schipilow J, Hirano Y, Ngan DA, et al. Lung exposure to lipopolysaccharide causes atherosclerotic plaque destabilisation. Eur Respir J. 2016;48:205\u201315.","journal-title":"Eur Respir J"},{"key":"2117_CR165","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jama.2014.18229","volume":"313","author":"VF Corrales-Medina","year":"2015","unstructured":"Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang C-CH, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313:264\u201374.","journal-title":"JAMA"},{"key":"2117_CR166","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1164\/rccm.201801-0139WS","volume":"198","author":"CS Dela Cruz","year":"2018","unstructured":"Dela Cruz CS, Wunderink RG, Christiani DC, Cormier SA, Crothers K, Doerschuk CM, et al. Future research directions in pneumonia. NHLBI working group report. Am J Respir Crit Care Med. 2018;198:256\u201363.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02117-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02117-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02117-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T03:06:16Z","timestamp":1668827176000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02117-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,10]]},"references-count":166,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02117-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,10]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interests relevant to the content of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}